A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : bsAbs

Search Conditions:
Search Keyword : bsAbs
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: bsAbs
Appearance Frequency: 146 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
bispecific antibodies
(112 times)
Allergy and Immunology
(22 times)
mAbs (12 times)
scFv (7 times)
EGFR (5 times)
1991 Bispecific antibodies and targeted cellular cytotoxicity.
Bispecific antibodies
(25 times)
Biochemistry
(8 times)
mAbs (4 times)
EGFR (3 times)
scFv (3 times)
1999 Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: a pre-clinical study.
Bi-specific antibodies
(2 times)
Chemistry
(1 time)
EC (1 time)
sdAbs (1 time)
2008 Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.
bispecific monoclonal antibodies
(2 times)
Hematology
(1 time)
ALL-B (1 time)
BsAb (1 time)
IL-2 (1 time)
1995 The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.
Bispecific monoclonal antibodies
(2 times)
Histocytochemistry
(1 time)
PBMCs (1 time)
PC (1 time)
1995 Bispecific monoclonal antibody therapy of B-cell malignancy.
anti-B-cell antigen bispecific monoclonal antibodies
(1 time)
Neoplasms
(1 time)
BsIgG (1 time)
FcR (1 time)
1998 Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.
Bi- and multispecific antibody derivatives
(1 time)
Neoplasms
(1 time)
--- 2014 Tumor-antigen-binding bispecific antibodies for cancer treatment.
bispecific antibody derivatives
(1 time)
Biochemistry
(1 time)
--- 2019 Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids.